Alyeska Investment Group
LEGN icon

Alyeska Investment Group’s Legend Biotech LEGN Stock Holding History

Alyeska Investment Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.88M Buy
307,474
+296,968
+2,827% +$8.01M 0.02% 442
2026
Q1 		$190K Buy
+10,506
New +$200K ﹤0.01% 600
2025
Q1 		– Sell
-250,000
Closed -$8.13M – 596
2024
Q4 		$8.13M Buy
+250,000
New +$10.4M 0.03% 359
2024
Q3 		– Sell
-10,513
Closed -$466K – 623
2024
Q2 		$466K Buy
+10,513
New +$485K ﹤0.01% 507
2020
Q3 		– Sell
-50,400
Closed -$2.15M – 536
2020
Q2 		$2.15M Buy
+50,400
New +$1.97M 0.03% 352

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Alyeska Investment Group's LEGN Position: Q2 2026 in Review

Alyeska Investment Group increased its Legend Biotech (LEGN) stake by 2,827% in Q2 2026, buying an estimated $8.01M and bringing the position to 307,474 shares worth $8.88M. The position accounts for 0.02% of the portfolio, ranked #442.

Alyeska Investment Group first reported a position in LEGN in Q2 2020 and has held it in 5 quarters since. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Alyeska Investment Group held 307,474 shares of Legend Biotech worth $8.88M as of Q2 2026.
  • Alyeska Investment Group bought 296,968 Legend Biotech shares in Q2 2026, an estimated $8.01M.
  • Legend Biotech made up 0.02% of Alyeska Investment Group's portfolio in Q2 2026, its #442 holding.
  • Alyeska Investment Group first reported a position in Legend Biotech in Q2 2020 and has held it in 5 quarters since.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.